Table 6 Variations existing in the efficacy of seven novel biologics

 − 2.52

(− 9.51, 4.47)

Zilucoplan

 − 4.02

(− 9.51, 1.48)

 − 1.50 (− 6.70, 3.70)

Batoclimab

 − 5.40

(− 11.08, 0.28)

 − 2.88 (− 8.28, 2.52)

 − 1.38 (− 4.63, 1.87)

Ravulizumab

 − 7.89 (− 14.40, − 1.38)

 − 5.37 (− 11.63, 0.90)

 − 3.87 (− 8.41, 0.67)

 − 2.49 (− 7.26, 2.28)

Rituximab

 − 6.36 (− 12.12, − 0.61)

 − 3.84 (− 9.32, 1.63)

 − 2.34 (− 5.72, 1.03)

 − 0.96 (− 4.63, 2.71)

1.53

(− 3.33, 6.38)

Efgartigimod

 − 7.10 (− 12.20, − 2.00)

 − 4.58 (− 9.36, 0.20)

 − 3.08 (− 5.14, − 1.03)

 − 1.70 (− 4.22, 0.82)

0.79

(− 3.26, 4.84)

 − 0.74

(− 3.41, 1.94)

Placebo